Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorNarayanasamy, Shanti
dc.contributor.authorOkware, Brenda
dc.contributor.authorMuttamba, Winters
dc.contributor.authorPatel, Kirtika
dc.contributor.authorDuedu, Kwabena Obeng
dc.contributor.authorRavi, Nirmal
dc.contributor.authorEllermeier, Nathan
dc.contributor.authorShey, Muki
dc.contributor.authorWoods, Christopher W
dc.contributor.authorSabiiti, Wilber
dc.contributor.authorCOVID-19 Clinical Research Coalition, Virology, Immunology, and Diagnostics Working Group
dc.date.accessioned2022-09-21T10:30:17Z
dc.date.available2022-09-21T10:30:17Z
dc.date.issued2022-10-06
dc.identifier.citationNarayanasamy , S , Okware , B , Muttamba , W , Patel , K , Duedu , K O , Ravi , N , Ellermeier , N , Shey , M , Woods , C W , Sabiiti , W & COVID-19 Clinical Research Coalition, Virology, Immunology, and Diagnostics Working Group 2022 , ' The global inequity of COVID-19 diagnostics : challenges and opportunities ' , Journal of Epidemiology and Community Health , vol. Early . https://doi.org/10.1136/jech-2022-219333en
dc.identifier.issn0143-005X
dc.identifier.otherPURE: 281394815
dc.identifier.otherPURE UUID: 1c15305f-87cf-4c5f-95f1-1bbbdc82268e
dc.identifier.otherORCID: /0000-0002-4742-2791/work/120849886
dc.identifier.otherWOS: 000865495200001
dc.identifier.urihttp://hdl.handle.net/10023/26048
dc.description.abstractDiagnostics for COVID-19 have advanced at an unprecedented pace over the last two years. Testing is a critical pillar of pandemic control, and is required for epidemiological tracking, treatment, and surveillance. Despite high quality SARS-CoV-2 viral diagnostic capability, there are vast global inequities in access. The Virology, Immunology, and Diagnostics Working Group(WG) of the COVID-19 Clinical Research Coalition (CRC) brings together experts in immunology, infectious diseases, and microbiology to advocate for equity-based COVID-19 research, prioritising solutions driven by communities in low-income and lower middle-income countries (LMICs).1 This commentary shares the unique perspective of the WG on the asymmetry in COVID-19 diagnostic access between low-income and high-income settings, the barriers to these disparities, and highlights opportunities to remedy these inequities.
dc.format.extent4
dc.language.isoeng
dc.relation.ispartofJournal of Epidemiology and Community Healthen
dc.rightsCopyright © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This work has been made available online in accordance with publisher policies or with permission. Permission for further reuse of this content should be sought from the publisher or the rights holder. This is the author created accepted manuscript following peer review and may differ slightly from the final published version. The final published version of this work is available at http://dx.doi.org/10.1136/jech-2022-219333.en
dc.subjectCOVID-19en
dc.subjectHV Social pathology. Social and public welfareen
dc.subjectRA0421 Public health. Hygiene. Preventive Medicineen
dc.subjectT-DASen
dc.subject.lccHVen
dc.subject.lccRA0421en
dc.titleThe global inequity of COVID-19 diagnostics : challenges and opportunitiesen
dc.typeJournal articleen
dc.description.versionPostprinten
dc.contributor.institutionUniversity of St Andrews. Infection and Global Health Divisionen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.identifier.doihttps://doi.org/10.1136/jech-2022-219333
dc.description.statusPeer revieweden


This item appears in the following Collection(s)

Show simple item record